December, 2021

NeuroScientific Biopharmaceuticals Investor Webinar Presentation – ShareCafe Small Cap “Hidden Gems”

NeuroScientific Biopharmaceuticals Director of Operations, Dr Alexandra Andrews provided an overview of the Company’s peptide-based drug for the treatment of neurodegenerative conditions and an update on the Company's progress towards clinical trials.